Savings Offer For The Eversense E3 CGM Extended To Cover Unlimited Number Of Systems
03/12/2024
|
|
Senseonics Holdings, Inc. Announces Data From the Eversense® Post Approval Study to Be Presented at the 17th International Conference on Advanced Technologies and Treatments for Diabetes
03/08/2024
|
|
Senseonics Holdings, Inc. to Participate in the Oppenheimer 34th Annual Healthcare MedTech and Services Conference
03/06/2024
|
|
Senseonics Holdings, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results
02/29/2024
|
|
Senseonics Holdings, Inc. Schedules Fourth Quarter and Full Year 2023 Earnings Release and Conference Call for February 29, 2024 at 4:30 P.M. Eastern Time
02/15/2024
|
|
Medicare Coverage Significantly Expanded for the Eversense E3 CGM System
02/12/2024
|
|
PHC Holdings Corporation and Senseonics Announce Appointment of Brian Hansen as President of CGM at Ascensia Diabetes Care
02/06/2024
|
|
Senseonics Holdings, Inc. Announces Business Updates
01/02/2024
|
|